Thought Leadership
When it comes to thought leadership and staying informed, we’ve got you covered. See below for recent articles, webinars, and downloadable resources available.
Want updates like these sent directly to your inbox?
AstraZeneca distributed letters recently that as of October 1, 2020, 340B pricing will be available only through “a single contract pharmacy for those covered entities that do not maintain their […]
In 2018, the Center for Medicare & Medicaid Services (CMS) implemented a change in reimbursement for DSHs, RRCs, and non-rural SCHs for Medicare Part B drugs obtained through the 340B […]
The Health Resources and Services Administration has set the annual recertification of eligibility for 340B drug discounts for hospitals to begin August 17, 2020 and end September 14, 2020. Mandatory […]
Merck & Co. is communicating directly with covered entities asking for contract pharmacy claim data to be submitted to Merck via a secure web portal. Merck states the data will […]
HRSA has indicated it will allow a hospital to accelerate timelines for its offsite locations to begin participating in the 340B Drug Discount Program. Previously, offsite locations were required to […]
The White House Office of Management and Budget (OMB) approved the Centers for Medicare & Medicaid Services’ (CMS) plan, proposed September 30, 2019, to survey 340B hospitals for their net […]
This article was originally published on March 25th and was updated on April 23rd. It is being updated as new information becomes available. We wanted to provide updates on the […]
We wanted to share an urgent update on the impending billing changes that were scheduled to take effect on 4/1/2020. In a communication we acquired today from Jessin Joseph, Pharmacy […]
Consolidated Health Center & FQHC Look-a-Likes The 2020 Grantee recertification period for Consolidated Health Centers, Federal Qualified Health Center Look-Alikes, Ryan White, Comprehensive Hemophilia Treatment Centers, Native Hawaiian, Black Lung […]
The Health Resources and Services Administration (HRSA) has set the annual recertification of eligibility for 340B drug discounts for hospitals to begin August 19, 2019, and end September 16, 2019. […]
Attention 340B covered entities participating with Anthem Blue Cross and Blue Shield: Effective April 1, 2019, Anthem requires that a “JG,” “TB,” or another relevant modifier be added to claims […]
Attention 340B covered entities participating with Humana – Managed Care Medicare: Effective January 1, 2019, Humana requires that a “JG,” “TB,” or another relevant modifier be added to claims involving […]
On December 28, 2018, a federal judge in Washington reversed the enormous cuts to Medicare OP Drug payments implemented by CMS which were effective January 1, 2018. U.S. District Judge Rudolph […]
Compliance is often a misunderstood word that most healthcare professionals associate with spending more time and money. Typically, compliance is defined as a certification or confirmation that the doer of […]
Webinars
The Health Resources and Services Administration (HRSA) has set the annual recertification window for the 340B Drug Pricing Program for hospitals from August 12, 2024 to September 9, 2024. The […]
This is your 340B recertification reminder for 2024. The 2024 Grantee recertification period for Consolidated Health Centers, Federal Qualified Health Center Look-Alikes, Ryan White, Comprehensive Hemophilia Treatment Centers, Native Hawaiian, […]
On November 2, 2023, the Centers for Medicare & Medicaid Services (CMS) released a final rule around the 340B outpatient prospective payment system (OPPS), outlining a plan to correct and […]
On Friday July 7th, 2023, CMS released a proposed rule outlining a plan to correct and reverse the 340B payment cuts from calendar years (CY) 2018 through 2022, including a […]
Great news for 340B hospitals impacted by the reimbursement reductions initiated by the Center for Medicare and Medicaid Services (CMS) on January 1, 2018. Recently, CMS announced that the 2023 […]
In June, the Supreme Court gave hospitals participating in the 340B Drug Pricing Program a convincing victory ruling unanimously that the U.S. Center for Medicare & Medicaid Services (CMS) should […]